Preliminary consolidated results of JSC Olainfarm for September, 2015 show that sales of the company during this period has reached 8.03 million euro, which represents a reduction by 5% compared to the same period of 2014. The biggest sales increases were achieved in Ukraine, where sales grew by 77% and Uzbekistan, where sales grew by 60%. Significant shipments have also been made to Germany and Australia. The major sales markets of JSC Olainfarm during September were Russia, Latvia, Ukraine, Belarus, The Netherlands and Poland.
| September 2015, consolidated sales | Share in total sales | Changes to September 2014 |
| Russia | 28% | -27% |
| Latvia | 26% | 5% |
| Ukraine | 15% | 77% |
| Belarus | 6% | -9% |
| The Netherlands | 5% | 21% |
| Poland | 5% | 8% |
| Uzbekistan | 3% | 60% |
| Germany | 2% | NA |
| Lithuania | 2% | 13% |
| Australia | 2% | NA |
| Other | 8% | -51% |
| Total | 100% | -5% |
Sales of pharmacy chain of Latvijas aptieka Ltd., fully owned by JSC Olainfarm were 1.43 million euros, which represents an increase by 8% compared to the same period of 2014; 57 pharmacies were operating during September. Sales of Silvanols Ltd. during September were 0.54 million euro, and this represents an increase by 15% compared to 2014. Silvanols was selling its products in six European countries directly. Sales to Kazakhstan were made via JSC Olainfarm.
According to preliminary consolidated results for nine months of 2015, sales of JSC Olainfarm during this period were 73.03 million euro, which represents an increase by 4% compared to nine months of 2014. The most rapid sales increases in nine months were achieved in The Netherlands, where sales grew by 181%. Major sales markets of JSC Olainfarm in nine months of 2015 were Russia, Latvia, Ukraine, Belarus and The Netherlands.
| 9 months of 2015, consolidated sales | Share in total sales | Changes to nine months of 2014 |
| Russia | 34% | -3% |
| Latvia | 23% | 9% |
| Ukraine | 12% | -15% |
| Belarus | 7% | -7% |
| The Netherlands | 7% | 181% |
| Kazakhstan | 2% | 2% |
| UK | 2% | -9% |
| Uzbekistan | 1% | -6% |
| Poland | 1% | -32% |
| Lithuania | 1% | 18% |
| Other | 9% | 28% |
| Total | 100% | 4% |
Sales of pharmacies of Latvijas aptieka Ltd. in nine months of 2105 were 12.2 million euro, which represents an increase by 10% compared to the same period of 2014. Sales of Silvanols Ltd. in nine months of 2015 were 2.9 million euro, which is an increase by 22% compared to 2014. Silvanols Ltd. during this period made sales in 13 countries on two continents. Sales to Kazakhstan and Azerbaijan were made via JSC Olainfarm.
According to preliminary unconsolidated results, sales of JSC Olainfarm during September 2015 were 6.87 million euro, which represents a reduction by 6% compared to the same period of 2014. The biggest sales increases were achieved in Ukraine, where sales grew by 77%, Uzbekistan, where sales grew by 60%, and Lithuania, where sales grew by 24%. During this month, significant shipments have also been made to Germany and Australia. Major sales markets of JSC Olainfarm in September 2015 were Russia, Ukraine, Latvia, Belarus and The Netherlands. During September 2015, products of JSC Olainfarm were sold in 24 countries on five continents.
| September 2015, unconsolidated sales | Share in total sales | Changes to September 2014 |
| Russia | 33% | -27% |
| Ukraine | 17% | 77% |
| Latvia | 17% | 21% |
| Belarus | 7% | -9% |
| The Netherlands | 6% | 21% |
| Poland | 4% | -20% |
| Uzbekistan | 3% | 60% |
| Germany | 2% | NA |
| Lithuania | 2% | 24% |
| Australia | 2% | NA |
| Other | 8% | -53% |
| Total | 100% | -6% |
According to preliminary unconsolidated results for nine months of 2015, sales of JSC Olainfarm during this period were 64.24 million euro, which represents an increase by 5% compared to the same period of 2014. The most rapid sales increases were achieved in The Netherlands, where sales grew by 181%, sales to Turkmenistan grew by 48%, sales to Tajikistan grew by 36%, and sales to Latvia grew by 31%. Major sales markets of AS Olainfarm in none months of 2015 were Russia, Latvia, Ukraine, Belarus and The Netherlands. In total in nine months JSC Olainfarm made sales in 41 countries on five continents.
| 9 months of 2015, unconsolidated sales | Share in total sales | Changes to 9 months of 2014 |
| Russia | 38% | -3% |
| Latvia | 14% | 31% |
| Ukraine | 14% | -15% |
| Belarus | 8% | -7% |
| The Netherlands | 8% | 181% |
| Kazakhstan | 3% | 2% |
| UK | 2% | -9% |
| Uzbekistan | 2% | -6% |
| Tajikistan | 1% | 36% |
| Turkmenistan | 1% | 48% |
| Other | 9% | 4% |
| Total | 100% | 5% |
Annual General Meeting of shareholders of JSC Olainfarm, held on June 11, 2015 approved operating plan of the company, according to which the unconsolidated sales of the company in 2015 will reach 87 million euros, while consolidated sales will reach 100 million euro. According to these preliminary sales figures, in nine months of 2015, the company has attained 74% of annual target for unconsolidated sales and 73% of annual target for consolidated sales.
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
Information prepared by:
Salvis Lapins
Member of the Board
JSC Olainfarm
Tel: +371 6 7013 717
Cell: +371 2 6448 873
E-mail: slapinsh@olainfarm.lv
